Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.
de la Rubia
Javier
J
Roig
Mónica
M
Ibáñez
Angela
A
García
Inmaculada
I
Vera
José A
JA
Aguilar
Carlos
C
del Campo
Raquel
R
González
Nicolás
N
Martínez
Rafael
R
Palomera
Luis
L
Picón
Isabel
I
Rodríguez
Juan N
JN
Sanz
Miguel A
MA
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006435:Renal Dialysis; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide